Fufeng Group Limited

Fufeng Group Limited

0546.HK
Fufeng Group LimitedHK flagHong Kong Stock Exchange
5.77
HKD
+0.04
- -
14.47BMarket Cap
Fufeng Group Limited
0546.HK
(Hong Kong Stock Exchange)

Recent

price

5.77

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
3.61
4.6
5.65
5.64
5.41
5.3
5.55
5.38
5.4
6.36
6.59
8.5
10.84
11.05
11.03
11.12
Revenue per Share
0.54
0.33
0.22
0.25
0.3
0.24
0.51
0.57
0.72
0.45
0.25
0.51
1.52
1.24
0.92
0.98
Basic EPS, GAAP
-0.17
-1.09
-0.54
-0.16
-0.42
0.11
0.32
-0.32
-0.13
-0.3
-0.32
0.9
1.01
-0.24
0.69
0.1
Free Cash Flow per Basic Share
0.21
0.2
0.02
0.02
0.06
0.07
0.04
0.15
0.13
0.29
0.13
0.12
0.43
0.51
0.48
0.54
Dividend per Share
1.63
1.75
1.78
1.95
2.17
2.37
2.84
3.03
3.53
3.95
4.19
4.56
5.53
6.24
6.68
7.1
Book Value per Share
1.77
1.72
1.74
2.14
1.73
2.03
2.54
3.32
4
4.16
4.29
4.67
5.77
6.46
6.89
7.34
Tangible Book Value per Share
1,776
1,825
1,967
2,014
2,090
2,119
2,127
2,423
2,547
2,541
2,534
2,534
2,535
2,535
2,517
2,507
Basic Weighted Avg Shares
6,416
8,399
11,112
11,367
11,298
11,226
11,803
13,034
13,765
16,171
16,691
21,540
27,475
28,007
27,757
27,879
Sales/Revenue/Turnover
17.2
9.14
6.41
8.05
9.69
8.67
11.93
13.46
7.87
9.19
5.77
7.85
16.9
12.46
8.08
8.97
Operating Margin (%)
254
368
533
698
719
766
854
894
1,061
1,156
1,253
1,245
1,159
1,124
1,214
1,301
Depreciation Expense
966
604
427
506
626
516
1,093
1,382
1,845
1,137
630
1,281
3,861
3,144
2,312
2,465
Net Income, GAAP
9.83
15.67
12.99
20.26
19.08
24.05
16.08
16.36
16.55
18.73
18.26
15.52
20.56
18.34
18.49
17.72
Effective Tax Rate (%)
15.06
7.19
3.84
4.45
5.54
4.6
9.26
10.61
13.4
7.03
3.77
5.95
14.05
11.23
8.33
8.84
Profit Margin (%)
18
144
-1,453
338
292
-653
-54
-101
2,985
3,181
2,329
5,828
6,464
5,671
6,292
5,459
Working Capital
981
2,844
2,045
3,309
3,702
1,992
1,923
560
2,487
2,450
464
2,506
585
147
349
200
LT Debt
3,145
3,407
3,795
4,819
5,369
5,807
6,816
9,460
11,004
11,376
11,689
12,678
15,494
17,324
18,343
19,460
Total Equity
25.79
11.05
8.11
8.25
8.94
7.34
11.98
13.58
6.71
8
5.24
8.86
19.06
11.65
6.39
6.12
Return on Invested Capital (%)
29.24
12.94
8.85
9.75
10
7.81
13.83
15.91
17.69
9.81
5.8
9.54
22.65
14.41
9.23
8.43
Return on Capital (%)
41.35
19.83
12.74
13.65
14.81
10.8
19.76
20.68
22.58
11.94
6.09
11.54
30.19
21.08
14.17
14.24
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.31%
10.89%
6.09%
Free Cash Flow
-90.87%
-192.28%
-86.12%
Net Income, GAAP
35.51%
53.28%
6.61%
Sales/Revenue/Turnover
9.99%
11.62%
0.44%
Total Cash Common Dividend
60.35%
57.01%
10.11%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
28,007
2024
- -
- -
- -
- -
27,757
2025
- -
- -
- -
- -
27,879

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.24
2024
- -
- -
- -
- -
0.92
2025
- -
- -
- -
- -
0.98

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.51
2024
- -
- -
- -
- -
0.48
2025
- -
- -
- -
- -
0.54
Business
Fufeng Group Limited, founded in 1999 and headquartered in Qingdao, China, is a leading manufacturer and supplier of biochemical fermentation products specializing in food additives, animal nutrition, high-end amino acids, and colloids. The company’s core product portfolio includes monosodium glutamate (MSG), xanthan gum, gellan gum, glutamic acid, starch sweeteners such as glucose and fructose, compound seasonings, corn oil, amino acids including threonine, lysine, L-valine, and isoleucine, as well as bio-fermentation fertilizers and chicken bouillon. Additionally, Fufeng produces healthcare products like cordycepin capsules and animal health supplements. The company sells its products domestically in China and exports to over 120 countries across North America, South America, Central Asia, Europe, and Russia, supported by five production plants in China and multiple overseas marketing centers. Fufeng Group operates through several business segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Others. The Food Additives segment features fermentation products like MSG, starch sweeteners, and compound seasonings. Animal Nutrition offers refined corn products and amino acids aimed at animal feed markets. The High-End Amino Acid segment focuses on specialty amino acids, while the Colloid segment provides xanthan gum and gellan gum products utilized in food, pharmaceuticals, and other industries. The Other segment encompasses fertilizers, synthetic ammonia, autoclaved aerated concrete blocks, pharmaceuticals, cosmetics, biological products, and logistics services. Fufeng's products are widely applied in food production, animal husbandry, healthcare, pharmaceuticals, and petroleum exploration industries. Recent major developments for Fufeng Group include the signing of a new export contract with a leading beverage manufacturer for amino acid supplies, enhancing its international sales outlook. The company also completed an equity buyback program in late 2023, repurchasing over 16 million shares. In 2025, Fufeng reported a strong financial performance with attributable profit increasing by over 70% year-on-year in interim results, reflecting robust demand and operational improvements. The company continues expanding its international footprint with overseas representative offices in key regions and pursuing strategic initiatives to enhance its product quality and global competitiveness amid ongoing trade challenges. The Group maintains a focus on diversification and high-value biochemical fermentation products as part of its long-term sustainable growth strategy. Fufeng Group is recognized as the world’s largest producer of MSG and xanthan gum, solidifying its leadership in the biochemical fermentation industry. The Group's extensive product range, global customer base, and continuous innovation position it as a major player in the global food additives and biochemical fermentation markets. It remains committed to scaling its international operations and diversifying its product offerings through research and development and strategic market expansion. Overall, Fufeng Group Limited is a diversified biochemical fermentation company with a broad product portfolio across food additives, animal nutrition, amino acids, and colloids, serving a global market. Recent contract wins, strong financial results, and share repurchases underscore its operational strength and strategic focus on international growth and product innovation. The company's operations span China and over 120 export markets with significant production capabilities and marketing infrastructure worldwide.